Press releases

dsm-firmenich, the leading innovator in health, nutrition, and beauty, has initiated legal action for patent infringement against Zhejiang Shengda Bio-pharm Co., Ltd. – a biotin supplier – and Anhui Shengda Bio-pharm Co., Ltd., a.k.a. Anhui Shengda Bio-engineering Co., Ltd. – a biotin intermediate manufacturer. The two companies are collectively referred to as “Shengda”. dsm-firmenich asserts that Shengda’s production of a key biotin intermediate at its Anhui site is an unlawful use of dsm-firmenich patented technology .  dsm-firmenich has petitioned the court in Anhui Province, China, to order Shengda to cease using the patented technology and pay compensation for the infringement.

A leading supplier of biotin for pharmaceutical, nutraceutical and feed applications,
dsm-firmenich developed the underlying technology for biotin intermediate production and works diligently to protect its innovations. Recently, dsm-firmenich was successful in enforcing the same patent in China against another Chinese biotin manufacturer, with both an injunction and compensation achieved and the validity of the patent remaining solid and affirmed before the Supreme People’s Court of China .

“dsm-firmenich’s biotin production  technology  is at the forefront of the industry in terms of quality and efficacy standards,” comments Kelsey Achenbach, Senior Director Pharma and Medical Nutrition at dsm-firmenich. “Our ongoing success in this market is due to our dedication to our customers and continuous investment in this high-quality ingredient. This litigation action will help protect our cutting-edge technologies and ensure we can continue to invest in biotin innovation.”

About dsm-firmenich,
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people.
www.dsm-firmenich.com

Follow us on: LinkedIn, Twitter, Facebook, Instagram
For more information
dsm-firmenich
Nelleke Barning
e-mail Nelleke.Barning@dsm.com

BDB
Catherine Butcher
tel. (44) 783 480 2415
e-mail catherine@bdb.co.uk

Forward-looking statements
This press release may contain forward-looking statements with respect to dsm-firmenich’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.